StonvexLoading…
StonvexStonvexStonvexCore line items from CCBG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $204.39M | $194.66M | $181.07M | $131.91M |
Operating Income | $81.72M | $65.57M | $63.86M | $41.08M |
Net Income | $61.56M | $52.91M | $52.26M | $33.41M |
EPS (Diluted) | $3.60 | $3.12 | $3.07 | $1.97 |
Total Assets | $4.39B | $4.32B | $4.30B | $4.52B |
Total Liabilities | $3.83B | $3.83B | $3.86B | $4.12B |
Cash & Equivalents | $529.97M | $391.85M | $312.07M | $600.65M |
Free Cash Flow OCF − CapEx | $80.03M | $54.88M | $47.74M | $86.37M |
Shares Outstanding | 17.08M | 16.97M | 16.95M | 16.99M |